| Stage | MTZ | % of rev | MYRG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.2B | 100.00% | $1.3B | 100.00% | MTZ ×4.09 |
| Gross profit | $661M | 12.83% | $171M | 13.60% | MYRG +0.8pp |
| Operating income | $275M | 5.35% | $85M | 6.76% | MYRG +1.4pp |
| Pre-tax income | $220M | 4.27% | $82M | 6.54% | MYRG +2.3pp |
| Net income | $168M | 3.26% | $60M | 4.77% | MYRG +1.5pp |
| Stage | MTZ | MYRG | Gap · A − B |
|---|---|---|---|
| Revenue | $5.2B100.00% | $1.3B100.00% | MTZ ×4.09 |
| Gross profit | 12.83%$661M | 13.60%$171M | MYRG +0.8pp |
| Operating income | 5.35%$275M | 6.76%$85M | MYRG +1.4pp |
| Pre-tax income | 4.27%$220M | 6.54%$82M | MYRG +2.3pp |
| Net income |
| 3.26%$168M |
| 4.77%$60M |
| MYRG +1.5pp |
No disclosed counterparties: MTZ, MYRG.